Clinical Trials | September 18, 2025
AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Encouraging early detection and breaking the silence around men’s health
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Subscribe To Our Newsletter & Stay Updated
